An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy
- PMID: 3663508
- DOI: 10.1111/j.1365-2141.1987.tb01337.x
An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy
Abstract
We have identified an inherited qualitative deficiency of antithrombin III (AT III) in a family with apparently no increased incidence of venous thrombosis. Plasma antithrombin and anti-Xa activities were normal, but the interaction with heparin, heparan sulphate and low molecular weight heparin was uniformly decreased. An immunoblotting technique performed in plasma showed normal complex formation with thrombin. By using heparin-Sepharose affinity chromatography and crossed immunoelectrophoresis, the variant could be separated: at least two fractions of low affinity AT III were obtained. A minor one had no antiprotease activity; the other one was further purified to homogeneity and found to have normal specific activity in absence of heparin and a 50% decreased activity in presence of heparin. We propose to call this new variant AT III Clichy.
Similar articles
-
Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.Br J Haematol. 1987 Aug;66(4):523-7. doi: 10.1111/j.1365-2141.1987.tb01338.x. Br J Haematol. 1987. PMID: 3663509
-
Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.Am J Hematol. 1995 Jan;48(1):12-8. doi: 10.1002/ajh.2830480104. Am J Hematol. 1995. PMID: 7832187
-
Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").J Clin Invest. 1986 Mar;77(3):887-93. doi: 10.1172/JCI112386. J Clin Invest. 1986. PMID: 3512602 Free PMC article.
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides.Nouv Rev Fr Hematol (1978). 1988;30(3):155-60. Nouv Rev Fr Hematol (1978). 1988. PMID: 2971155 Review.
-
The molecular pathology of inherited human antithrombin III deficiency.Transfus Med Rev. 1989 Oct;3(4):264-81. doi: 10.1016/s0887-7963(89)70087-0. Transfus Med Rev. 1989. PMID: 2520560 Review. No abstract available.
Cited by
-
Antithrombin III deficiency in a patient with recurrent venous thromboembolism: A case report.World J Clin Cases. 2023 Jul 16;11(20):4956-4960. doi: 10.12998/wjcc.v11.i20.4956. World J Clin Cases. 2023. PMID: 37583989 Free PMC article.
-
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.J Clin Invest. 1989 Oct;84(4):1236-42. doi: 10.1172/JCI114290. J Clin Invest. 1989. PMID: 2794060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous